Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001872873-26-000004

PRESIDENT AND CEO gave up 25,542 shares (to pay taxes)

  • PRESIDENT AND CEO acquired 80,062 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Option exercise +7,854 5,430,537 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Shares withheld for taxes −1,913 $3.55 $6,791 5,428,624 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Option exercise +14,733 5,443,357 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Shares withheld for taxes −3,588 $3.55 $12,737 5,439,769 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Option exercise +19,334 5,459,103 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Shares withheld for taxes −5,032 $3.55 $17,864 5,454,071 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Option exercise +38,141 5,492,212 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Shares withheld for taxes −15,009 $3.55 $53,282 5,477,203 D
Derivatives
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Option exercise · Restricted Stock Units −7,854 39,275 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Option exercise · Restricted Stock Units −14,733 162,073 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Option exercise · Restricted Stock Units −19,334 328,696 D
Jiang Wenbin PRESIDENT AND CEO 2026-05-18 Option exercise · Restricted Stock Units −38,141 877,266 D
Loading xslF345X06/form4-05202026_090527.xml…